
|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Brands of the Year: Promise and Challengealmost 8 years ago
Gauging the Collaborative Spirit in European Healthalmost 8 years ago
Gottlieb Tackles Drug Competition & Costsalmost 8 years ago
Deploying the Cloud in GxP Environmentsalmost 8 years ago
So Much Depends on the Physicianalmost 8 years ago
Bridging Science & Strategy: An Investor’s Eyealmost 8 years ago
Patient Empowerment and the Future of Pharma Advertisingalmost 8 years ago
Closing Pharma’s Digital Dividealmost 8 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsalmost 8 years ago
The Total Care PackageNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Vinay Prasad Out at CBER for Second Time in Under a Year
2
Key Factors Contributing to Uncertainty in Moderna's mRNA Vaccine Review
3
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
4
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
5




